MedTrace Logo

High Sensitivity cTnT Rules Out Cardiac Insufficiency Trial (TACIT)

NCT02592135 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2018-06-04

No results posted yet for this study

Summary

The purpose of this study is to better understand myocardial injury in AHF. Secondary analyses demonstrate the prognostic significance of troponin release. The absence of such release has been associated with less risk. Whether measurement of high sensitivity TnT may enable emergency physicians to better risk stratify acute heart failure patients remains to be determined. This study will help us to better understand the prognostic value of absent or low hsTnT values in the emergency department setting. In addition, we will also test the STRATIFY decision rule; a risk score.

Conditions

Interventions

OTHER

hsTnT level

hsTnT and NTproBNP levels at baseline and baseline plus 3 hours.

Sponsors & Collaborators

  • Vanderbilt University

    collaborator OTHER

  • Wayne State University

    collaborator OTHER

  • University of Cincinnati

    collaborator OTHER

  • Indiana University

    lead OTHER

Principal Investigators

  • Peter S Pang, MD · Indiana University

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-21
Primary Completion
2017-11-07
Completion
2018-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02592135 on ClinicalTrials.gov